LLVK

Overview

LLVK is a selective IκB phosphorylation inhibitor. LLVK reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6 , TNF-α). LLVK is promising for research of inflammatory bowel disease and rheumatoid arthritis.

Application

Products | Products > Peptides | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > IKK | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-P11296
• CAS No.: 798540-36-0
• Molecular Formula: C23H45N5O5
• Molecular Weight: 471.63
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source